Dodge & Cox — ALNY Trade History
Quarter-by-quarter changes in the Alnylam Pharmaceuticals, Inc. position · CUSIP 02043Q107
Currently held · >10 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Add | 1,955,393 | 26,140 | +1.4% | $588.6M | 0.31% |
| 2026 Q1 | 2026-05-14 | Reduce | 1,929,253 | -35,162 | -1.8% | $638.3M | 0.35% |
| 2025 Q4 | 2026-02-13 | Reduce | 1,964,415 | -356,815 | -15.4% | $781.1M | 0.42% |
| 2025 Q3 | 2025-11-13 | Reduce | 2,321,230 | -875,866 | -27.4% | $1.06B | 0.57% |
| 2025 Q2 | 2025-08-13 | Reduce | 3,197,096 | -154,666 | -4.6% | $1.04B | 0.59% |
| 2025 Q1 | 2025-05-14 | Reduce | 3,351,762 | -188,500 | -5.3% | $905.0M | 0.52% |
| 2024 Q4 | 2025-02-13 | Reduce | 3,540,262 | -82,273 | -2.3% | $833.1M | 0.48% |
| 2024 Q3 | 2024-11-13 | Reduce | 3,622,535 | -157,650 | -4.2% | $996.3M | 0.56% |
| 2024 Q2 | 2024-08-13 | Reduce | 3,780,185 | -31,295 | -0.8% | $918.6M | 0.55% |
| 2024 Q1 | 2024-05-14 | Add | 3,811,480 | 137,170 | +3.7% | $569.6M | 0.33% |
| 2023 Q4 | 2024-02-22 | Reduce | 3,674,310 | -72,845 | -1.9% | $703.3M | 0.45% |
| 2023 Q3 | 2023-11-14 | Reduce | 3,747,155 | -42,370 | -1.1% | $663.6M | 0.45% |
| 2023 Q2 | 2023-08-14 | Reduce | 3,789,525 | -105,010 | -2.7% | $719.8M | 0.48% |
| 2023 Q1 | 2023-05-12 | Reduce | 3,894,535 | -696,247 | -15.2% | $780.2M | 0.53% |
| 2022 Q4 | 2023-02-14 | Reduce | 4,590,782 | -298,515 | -6.1% | $1.09B | 0.75% |
| 2022 Q3 | 2022-11-10 | Reduce | 4,889,297 | -369,659 | -7.0% | $978.6M | 0.74% |
| 2022 Q2 | 2022-08-12 | Reduce | 5,258,956 | -216,712 | -4.0% | $767.0M | 0.53% |
| 2022 Q1 | 2022-05-13 | Add | 5,475,668 | 44,600 | +0.8% | $894.1M | 0.54% |
| 2021 Q4 | 2022-02-14 | Add | 5,431,068 | 58,968 | +1.1% | $921.0M | 0.57% |
| 2021 Q3 | 2021-11-15 | Reduce | 5,372,100 | -41,901 | -0.8% | $1.01B | 0.66% |
| 2021 Q2 | 2021-08-13 | Add | 5,414,001 | 1,092,374 | +25.3% | $917.8M | 0.60% |
| 2021 Q1 | 2021-05-14 | Reduce | 4,321,627 | -318,286 | -6.9% | $610.2M | 0.44% |
| 2020 Q4 | 2021-02-11 | Reduce | 4,639,913 | -37,700 | -0.8% | $603.0M | 0.48% |
| 2020 Q3 | 2020-11-13 | Reduce | 4,677,613 | -26,058 | -0.6% | $681.1M | 0.62% |
| 2020 Q2 | 2020-08-13 | Reduce | 4,703,671 | -389,675 | -7.7% | $696.7M | 0.64% |
| 2020 Q1 | 2020-05-14 | Reduce | 5,093,346 | -157,975 | -3.0% | $554.4M | 0.60% |
| 2019 Q4 | 2020-02-13 | Reduce | 5,251,321 | -60,480 | -1.1% | $604.8M | 0.46% |
| 2019 Q3 | 2019-11-13 | Add | 5,311,801 | 70,300 | +1.3% | $427.2M | 0.35% |
| 2019 Q2 | 2019-08-13 | Add | 5,241,501 | 243,500 | +4.9% | $380.3M | 0.31% |
| 2019 Q1 | 2019-05-14 | Add | 4,998,001 | 307,750 | +6.6% | $467.1M | 0.38% |
| 2018 Q4 | 2019-02-14 | Add | 4,690,251 | 34,600 | +0.7% | $342.0M | 0.31% |
| 2018 Q3 | 2018-11-21 | Add | 4,655,651 | 950 | +0.0% | $407.5M | 0.31% |
| 2018 Q2 | 2018-08-14 | Reduce | 4,654,701 | -38,140 | -0.8% | $458.4M | 0.37% |
| 2018 Q1 | 2018-05-14 | Reduce | 4,692,841 | -3,538,754 | -43.0% | $558.9M | 0.45% |
| 2017 Q4 | 2018-02-14 | Reduce | 8,231,595 | -909,900 | -10.0% | $1.05B | 0.81% |
| 2017 Q3 | 2017-11-13 | Reduce | 9,141,495 | -44,325 | -0.5% | $1.07B | 0.86% |
| 2017 Q2 | 2017-08-11 | Reduce | 9,185,820 | -213,425 | -2.3% | $732.7M | 0.62% |
| 2017 Q1 | 2017-05-12 | Add | 9,399,245 | 194,295 | +2.1% | $481.7M | 0.41% |
| 2016 Q4 | 2017-03-20 | Add | 9,204,950 | 3,928,882 | +74.5% | $344.6M | 0.31% |
| 2016 Q3 | 2016-11-14 | New | 5,276,068 | 5,276,068 | — | $357.6M | 0.34% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.